Found 6 matching trials
An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies
PHASE3The purpose of this study is to examine the long-term safety and tolerabili...
Location
Barrow Neurological Institute
Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)
PHASE2This is a phase II, multicenter, open-label, imaging study of hCRF in the r...
Location
Multiple Locations
Tolerability Study of Xerecept® in Pediatric Patients
PHASE1This study is being conducted to evaluate the safety and tolerability of Xe...
Location
Children's Memorial Hospital, Northwestern University Feinberg School of Medicine
XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors
PHASE3The purpose of this study is to compare the safety and efficacy of XERECEPT...
Location
Barrow Neurological Institute
XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
PHASE3The purpose of this study is to examine the safety and efficacy of XERECEPT...
Location
Barrow Neurological Institute
Xerecept Intravenous Dose Escalation in Japanese and Caucasian Volunteers
PHASE11. To investigate the safety and tolerability of Xerecept during and follow...
Location
West Coast Clinical Trials